Medigus

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jun 2, 2022	Upstream Bio	$200.0M Series A	Maruho, Erez Chimovits, OrbiMed	Access Biotechnology, Altshuler Shaham, Decheng Capital, HBM Healthcare Investments, Omega Funds, Samsara BioCapital, Bernard Davitian, TCGX